Crimson Publishers Publish With Us Reprints e-Books Video articles

Full Text

Global Journal of Endocrinological Metabolism

New Approach in the Treatment of Subacute Thyroiditis: ECE Protocol

Mehmet Celik*

Bilecik State Hospital, Department of Endocrinology and Metabolism, Turkey

*Corresponding author: Mehmet Celik, Bilecik State Hospital, Department of Endocrinology and Metabolism, Bilecik, Turkey

Submission: September 11, 2018; Published: October 10, 2018

DOI: 10.31031/GJEM.2018.02.000549

ISSN 2637-8019
Volume2 Issue4

Abstract

Subacute thyroiditis develops as a result of viral infections and/or postviral inflammatory responses. Severe pain and tenderness are present in the thyroid gland. The subacute thyroiditis treatment recommendation is mostly based on clinical experience. we aimed to present a new approach (ECE protocol) in patients who did not recur in follow-up for at least 6months after treatment.

Keywords: Subacute thyroiditis; New approach; Treatment

Introduction

Subacute thyroiditis is the most common cause of painful thyroid gland disease. The disease was first described by Fritz De Quervain in 1904. It is a self-limiting disease that usually occurs after viral upper respiratory tract infection. In the pathophysiology (Table 1), the apoptosis of the follicular epithelium and the deterioration of the follicle integrity are essential. The disease rate increases in young adults and decreases in later ages. Subacute thyroiditis is 3.5-4 times more common in females than males. It is most commonly seen in August and September [1-6]. The subacute thyroiditis treatment recommendation is mostly based on clinical experience. In this presentation, we aimed to present a new approach in patients who did not recur in follow-up for at least 6 months after treatment [4].

Table 1: Subacute thyroiditis treatment with ECE protocol.


  1. Check after 3 months if complete recovery is achieved. The patient should be informed about
  2. recurrence.
  3. If there is improvement in the laboratory but the subacute trioid is continuing clinically and
  4. radiologically; monthly control with methylprednisolone 4mg x 1 maintenance treatment.
  5. If the clinical improvement is not achieved after methylprednisolone within 3 days of treatment, the
  6. patient should be reevaluated for differential diagnosis.
  7. Metformin can be initiated with impaired fasting glucose and impaired glucose tolerance in patients
  8. with dietary and lifestyle changes [5-6].
  9. In patients with dyspeptic complaints, the proton pump inhibitor should be started with the treatment.
  10. Iodine-restricted diet in dietician partnership.
  11. Beta-blocker therapy may be given temporarily in patients with early onset tachycardia.

Conclusion

Patients who received ECE protocol treatment had no recurrence within 6 months. We think that ECE protocol is effective according to clinical experience..

References

  1. Shrestha RT, Hennessey J (2015) Acute and subacute, and Riedel’s thyroiditis. In: Degroot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A (Eds.), South Dartmouth, MA, USA.
  2. Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. The New England Journal of Medicine 348(26): 2646-2655.
  3. Kitchener MI, Chapman IM (1989) Subacute thyroiditis: a review of 105 cases. Clin Nucl Med 14(6): 439-442.
  4. Fallahi P, Ferrari SM, Ruffilli I, Elia G, BiricoC M, et al. (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15(12): 1125-1128.
  5. Lee YJ, Kim DW (2016) Sonographic characteristics and interval changes of subacute thyroiditis. J Ultrasound Med 35(8): 1653-1659.
  6. Sato J, Uchida T, Komiya K, Goto H, Takeno K, et al. (2017) Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55(1): 209-214.

© 2018 Mehmet C. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.



About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com